Mimedx (MDXG) Debt to Equity (2016 - 2025)
Mimedx (MDXG) has disclosed Debt to Equity for 11 consecutive years, with $0.07 as the latest value for Q4 2025.
- Quarterly Debt to Equity fell 28.18% to $0.07 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.07 through Dec 2025, down 28.18% year-over-year, with the annual reading at $0.07 for FY2025, 28.18% down from the prior year.
- Debt to Equity hit $0.07 in Q4 2025 for Mimedx, down from $0.08 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $586.91 in Q4 2021 to a low of -$8.27 in Q3 2021.
- Historically, Debt to Equity has averaged $29.11 across 5 years, with a median of $0.07 in 2025.
- Biggest five-year swings in Debt to Equity: plummeted 375.47% in 2021 and later skyrocketed 1582.54% in 2023.
- Year by year, Debt to Equity stood at $586.91 in 2021, then tumbled by 100.46% to -$2.7 in 2022, then skyrocketed by 112.73% to $0.34 in 2023, then crashed by 71.66% to $0.1 in 2024, then fell by 28.18% to $0.07 in 2025.
- Business Quant data shows Debt to Equity for MDXG at $0.07 in Q4 2025, $0.08 in Q3 2025, and $0.09 in Q2 2025.